Results
|
3881.
|
|
|
3882.
|
|
|
3883.
|
|
|
3884.
|
|
|
3885.
|
|
|
3886.
|
|
|
3887.
|
|
|
3888.
|
|
|
3889.
|
|
|
3890.
|
|
|
3891.
|
|
|
3892.
|
|
|
3893.
|
|
|
3894.
|
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer. [electronic resource] by
- Druzhyna, Nadiya
- Szczesny, Bartosz
- Olah, Gabor
- Módis, Katalin
- Asimakopoulou, Antonia
- Pavlidou, Athanasia
- Szoleczky, Petra
- Gerö, Domokos
- Yanagi, Kazunori
- Törö, Gabor
- López-García, Isabel
- Myrianthopoulos, Vassilios
- Mikros, Emmanuel
- Zatarain, John R
- Chao, Celia
- Papapetropoulos, Andreas
- Hellmich, Mark R
- Szabo, Csaba
Producer: 20171220
In:
Pharmacological research vol. 113
Availability: No items available.
|
|
3895.
|
|
|
3896.
|
|
|
3897.
|
High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancer. [electronic resource] by
- Sawada, Ryoichi
- Arai, Yoshinori
- Sagawa, Yukiko
- Nagata, Yusuke
- Nishimura, Takashi
- Noguchi, Masaaki
- Amano, Katsushi
- Arihiro, Seiji
- Saruta, Masayuki
- Homma, Sadamu
Producer: 20200227
In:
Oncology reports vol. 42
Availability: No items available.
|
|
3898.
|
|
|
3899.
|
|
|
3900.
|
|